Literature DB >> 1120753

Excretion of retained fluoride in man.

H Spencer, L Kramer, D Osis, E Wiatrowski.   

Abstract

In fluoride studies performed in man the excess fluoride excretions in urine and stool over and above the base-line excretions were determined following the discontinuation of fluoride supplements. The fluoride supplements contained either 9.1 mg fluoride as sodium fluoride, given daily for 32 days, or 7.6 mg fluoride as fish protein concentrate (FPC), given daily for 26 days. Following discontinuation of these fluoride supplements the excess fluoride excretions were low and of short duration, in most cases for 6-12 days. Since the fluoride supplements were given for a known period of time, the fluoride retention could be calculated from the fluoride balances, and the excess fluoride excretion corresponded to 9.1% of the retained fluoride given as NaF and to 14.1% of the retained fluoride given as FPC. The excess fluoride was predominantly excreted via the kidney, i.e., 87% of the total excess fluoride excretion was passed in urine and only 13% in stool.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120753     DOI: 10.1152/jappl.1975.38.2.282

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  3 in total

1.  Effect of age on the disposition of sodium fluoride.

Authors:  C Jeandel; F Lapicque; P Netter; B Bannwarth; C Monot; P Gillet; E Payan; M Guillaume; G Cuny
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Effect of discontinuation of fluoride intake from water and toothpaste on urinary excretion in young children.

Authors:  Carolina C Martins; Saul M Paiva; Jaime A Cury
Journal:  Int J Environ Res Public Health       Date:  2011-06-10       Impact factor: 3.390

3.  The use of urinary fluoride excretion to facilitate monitoring fluoride intake: A systematic scoping review.

Authors:  Oladipo S Idowu; Liane B Azevedo; Ruth A Valentine; Josie Swan; Priyanka V Vasantavada; Anne Maguire; Fatemeh V Zohoori
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.